BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12367531)

  • 1. X-ray crystal structure of the C4d fragment of human complement component C4.
    van den Elsen JM; Martin A; Wong V; Clemenza L; Rose DR; Isenman DE
    J Mol Biol; 2002 Oct; 322(5):1103-15. PubMed ID: 12367531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4.
    Blanchong CA; Chung EK; Rupert KL; Yang Y; Yang Z; Zhou B; Moulds JM; Yu CY
    Int Immunopharmacol; 2001 Mar; 1(3):365-92. PubMed ID: 11367523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemical structure of the C4d fragment of the human complement component C4.
    Chakravarti DN; Campbell RD; Porter RR
    Mol Immunol; 1987 Nov; 24(11):1187-97. PubMed ID: 3696167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
    Ebanks RO; Isenman DE
    Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination.
    Giles CM; Davies KA; Walport MJ
    Transfusion; 1991; 31(3):222-8. PubMed ID: 1706118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35).
    Clemenza L; Isenman DE
    J Immunol; 2004 Feb; 172(3):1670-80. PubMed ID: 14734749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    Isenman DE; Young JR
    J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic determinants of human C4, Rodgers and Chido.
    Giles CM
    Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4.
    Reilly BD; Levine RP; Skanes VM
    J Immunol; 1991 Nov; 147(9):3018-23. PubMed ID: 1919003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
    Ebanks RO; Isenman DE
    J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a surface structure in the fourth component of human complement, C4, which becomes hidden upon activation by C1(-)s.
    Maeda S; Takamaru Y; Fukatsu J; Nagasawa S
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):503-8. PubMed ID: 7678736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
    J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement.
    Mortensen S; Kidmose RT; Petersen SV; Szilágyi Á; Prohászka Z; Andersen GR
    J Immunol; 2015 Jun; 194(11):5488-96. PubMed ID: 25911760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling of human complement component C4 and its fragments by X-ray and neutron solution scattering.
    Perkins SJ; Nealis AS; Sim RB
    Biochemistry; 1990 Feb; 29(5):1167-75. PubMed ID: 2322556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T; Dodds AW; Law SK; Inoue K
    Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.
    Taillon-Miller PA; Shreffler DC
    J Immunol; 1988 Oct; 141(7):2382-7. PubMed ID: 2459207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
    Inal JM; Schifferli JA
    J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.
    Roos MH; Giles CM; Demant P; Mollenhauer E; Rittner C
    J Immunol; 1984 Nov; 133(5):2634-40. PubMed ID: 6207239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.